Osaic Holdings’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Osaic Holdings’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,891	Closed	-$6K	–	7859
2022 Q1	$6K	Buy	3,891 +69	+2%	+$123	﹤0.01%	6441
2021 Q4	$9K	Buy	3,822 +69	+2%	+$281	﹤0.01%	6379
2021 Q3	$20K	Hold	3,753	–	–	﹤0.01%	5798
2021 Q2	$28K	Buy	+3,753	New	+$26.6K	﹤0.01%	5458

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Osaic Holdings's KLDO Position: Q2 2022 in Review

Osaic Holdings sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 3,891 shares — an estimated $6K sold.

Osaic Holdings first reported a position in KLDO in Q2 2021 and held it in 4 quarters. The position peaked at $28K in Q2 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Osaic Holdings reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Osaic Holdings sold 3,891 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $6K.
Osaic Holdings first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Osaic Holdings's Kaleido Biosciences, Inc. Common Stock position peaked at $28K in Q2 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Osaic Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.